Arcus Biosciences Market Sentiment

SPY771.54+0.25%QQQ726.47−0.34%BTC/USD82,380.81+1.00%DIA521.42+1.12%GLD381.79+1.54%TLT80.35+1.85%

Premium

Arcus Biosciences Inc

RCUSNYSE

Trade with Public

$22.84

0.311.38%

Last update: Oct 15, 4:28 PM

$22.82

0.291.29%

Overview News Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Arcus Biosciences Market Sentiment

Market sentiment signals for Arcus Biosciences (RCUS): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 17.1% short float

Options Flow▼ 1.95 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

19 analysts

Options Flow (P/C)

1.95

More puts — Bearish

22 calls · 43 puts

Avg Consensus PT

$36

+58.3%

Highest Price Target

$50

+119.1%

Truist Securities

Lowest Price Target

$14

-38.7%

Barclays

Short Interest

17.1%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 14, 2026	JP Morgan	Priyanka Grover—	+79.7%	$41	Initiate	Overweight
Sep 30, 2026	Wedbush	Robert Driscoll—	+88.4%	$43 → $43	Maintained	Outperform
Sep 16, 2026	TD Cowen	Tara Bancroft—	—	—	Initiate	Buy
Sep 8, 2026	Truist Securities	Supawat Thongthip—	+75.3%	$35 → $40	Maintained	Buy
Aug 6, 2026	Wells Fargo	Eva Fortea Verdejo—	+13.9%	$23 → $26	Maintained	Equal-Weight
Aug 6, 2026	Wedbush	Robert Driscoll—	+88.4%	$41 → $43	Maintained	Outperform
Jul 20, 2026	HC Wainwright & Co.	Emily Bodnar—	+97.2%	$32 → $45	Maintained	Buy
Jun 4, 2026	LifeSci Capital	Charles Zhu—	+101.6%	$46	Initiate	Outperform
May 18, 2026	Truist Securities	Supawat Thongthip—	+53.4%	$30 → $35	Assumes	Buy
May 11, 2026	Morgan Stanley	Terence Flynn—	-3.6%	$20 → $22	Maintained	Equal-Weight
May 7, 2026	Goldman Sachs	Richard Law—	+49.0%	$30 → $34	Maintained	Buy
Apr 2, 2026	Wedbush	Robert Driscoll—	+79.7%	$37 → $41	Maintained	Outperform
Mar 5, 2026	Citigroup	Yigal Nochomovitz—	+97.2%	$44 → $45	Maintained	Buy
Mar 2, 2026	Leerink Partners	Geoffrey Porges—	+114.7%	$36 → $49	Maintained	Outperform
Mar 2, 2026	HC Wainwright & Co.	Emily Bodnar—	+40.2%	$32 → $32	Maintained	Buy
Feb 12, 2026	Wells Fargo	Eva Fortea Verdejo—	+0.8%	$30 → $23	Downgrade	Overweight→Equal-Weight
Jan 13, 2026	Goldman Sachs	Richard Law—	+22.7%	$16 → $28	Upgrade	Neutral→Buy
Jan 8, 2026	Morgan Stanley	Terence Flynn—	-12.4%	$23 → $20	Downgrade	Overweight→Equal-Weight
Dec 12, 2025	HC Wainwright & Co.	Emily Bodnar—	+40.2%	$28 → $32	Maintained	Buy
Nov 28, 2025	B of A Securities	Jason Zemansky—	+13.9%	$17 → $26	Maintained	Neutral
Oct 30, 2025	Goldman Sachs	Salveen Richter—	-29.9%	$14 → $16	Maintained	Neutral
Oct 29, 2025	Citigroup	Yigal Nochomovitz—	+145.4%	$54 → $56	Maintained	Buy
Oct 29, 2025	HC Wainwright & Co.	Emily Bodnar—	+22.7%	$24 → $28	Maintained	Buy
Oct 20, 2025	Wells Fargo	Eva Fortea Verdejo—	+27.1%	$25 → $29	Maintained	Overweight
Oct 13, 2025	Citigroup	Yigal Nochomovitz—	+136.6%	$47 → $54	Maintained	Buy